Tel: 123.456.7890

Shuang Liu, PhD, Founder & CEO  Co-inventor of CSTI-500. 20 years of experience in drug R&D as an integrated project leader. Led AMRI’s triple monoamine program which led to a multiple-year productive collaboration with BMS that delivered 4 NCEs, including CSTI-500, for clinical development. Led other successful discovery programs in CNS, oncology, and autoimmune at AMRI. Co-Inventor of >30 patent families. PhD in organic chemistry from the University of Georgia with postdoc training at Emory University. 

John Maki, Acting President  30 years of management and investment experience in life science. Formerly CEO of Vicus Therapeutics a clinical-stage immuno-oncology company, Managing Director at TDI and Audax Group, Principal at Bain Capital and Consultant at Bain & Company. Mr. Maki serves on the boards of Vicus Therapeutics and 3DMatrix as well as the Board of Trustees of BIO NJ. AB in Economics from Harvard University. 

Lois Rosenberger, PhD, Contract Regulatory and Clinical Operations Management  President of LBR Regulatory and Clinical Consulting Services. 30+ years of regulatory, quality assurance, and 20+ years of experience in managing clinical trials including for PWS. Lois held regulatory leadership positions at Kendle CRO, Marion-Merrell Dow, and P&G.  

Allen Ritter, PhD, Contract CMC  30 years of experience in the development, manufacturing, outsource manufacturing, and registration of pharmaceuticals. Former VP Manufacturing/CMC at Endocyte and CMC/QA management positions at Eli Lilly.   

Phone Number

(518) 275-0176

Email Address

info@consynance.com

Address

Health Sciences Campus

11 University Place

Rensselaer, NY 12144

Consynance Logo.png

Sign Up for ConSynance Updates

Get our news and updates on our progress and upcoming events.